Biotechnological medicines licensing process in Turkey Türkiye'de biyoteknolojik ilaçlara ilişkin ruhsatlandırma Süreci


Creative Commons License

Vural E. H., ÖZET A.

Gazi Medical Journal, cilt.30, sa.1, ss.102-106, 2019 (ESCI) identifier identifier

  • Yayın Türü: Makale / Derleme
  • Cilt numarası: 30 Sayı: 1
  • Basım Tarihi: 2019
  • Doi Numarası: 10.12996/gmj.2019.29
  • Dergi Adı: Gazi Medical Journal
  • Derginin Tarandığı İndeksler: Emerging Sources Citation Index (ESCI), Scopus
  • Sayfa Sayıları: ss.102-106
  • Anahtar Kelimeler: Biotechnology, licencing, regulations
  • Lokman Hekim Üniversitesi Adresli: Hayır

Özet

© Copyright 2019 by Gazi University Medical Faculty.In our country, medicines entry to the market are evaluated by the Turkish Pharmaceutical and Medical Devices Agency under the responsibility of the Republic of Turkey Ministry of Health. While the medicines market licensing processes of are evaluated, they are evaluated by taking into consideration the international acceptance criteria and the latest scientific developments on effectiveness, safety and quality standards. The licensing processes of biological/biotechnological products, which have importance gradually increased in recent years, have been reviewed taking into account basicly the legislative information.